| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 443913-15-3 | p38-α MAPK-IN-1 | MAPK-IN-1 MAPK-IN-1 443913-15-3 p38-α MAPK-IN-1 MAPK14 INHIBITOR p38-α MAPK inhibitor 1 Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]phenyl]- | ||
| 2 | 1245820-09-0 | Valsartan Acid Isopropyl Ester | Valsartan Acid Isopropyl Ester L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-methylethyl ester | ||
| 3 | 8-Phenethyl-3-[[4-(2-methoxyphenyl)piperazino]methyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione | 8-Phenethyl-3-[[4-(2-methoxyphenyl)piperazino]methyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione | |||
| 4 | 891264-65-6 | 3-AzetidinecarboxaMide, N-[(1S)-1-[5-(2-Methoxy-3-quinolinyl)-1H-iMidazol-2-yl]-7-oxononyl]-1-Methyl- | N-[(1S)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-7-oxononyl]-1-methylazetidine-3-carboxamide 3-AzetidinecarboxaMide, N-[(1S)-1-[5-(2-Methoxy-3-quinolinyl)-1H-iMidazol-2-yl]-7-oxononyl]-1-Methyl- | ||
| 5 | 151451-10-4 | N-(4-(2-(8-Cyclopentyl-2,6-dioxo-1-propyl-1H-purin-3(2H,6H,9H)-yl)ethyl)phenyl)cyclopentanecarboxamide | N-(4-(2-(8-Cyclopentyl-2,6-dioxo-1-propyl-1H-purin-3(2H,6H,9H)-yl)ethyl)phenyl)cyclopentanecarboxamide Cyclopentanecarboxamide, N-[4-[2-(8-cyclopentyl-1,2,6,9-tetrahydro-2,6-dioxo-1-propyl-3H-purin-3-yl)ethyl]phenyl]- Cyclopentanecarboxamide,N-[4-[2-(8-cyclopentyl-1,2,6,9-tetrahydro-2,6-dioxo-1-propyl-3H-purin-3-yl)ethyl]phenyl]- | ||
| 6 | 1-(6-CYCLOHEXANECARBONYL-2-PYRIDIN-2-YL-5,6,7,8-TETRAHYDRO-PYRIDO[4,3-D]PYRIMIDIN-4-YL)-PIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER | 1-(6-CYCLOHEXANECARBONYL-2-PYRIDIN-2-YL-5,6,7,8-TETRAHYDRO-PYRIDO[4,3-D]PYRIMIDIN-4-YL)-PIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|